Opportunity Information: Apply for RFA CA 22 039

The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) funding opportunity (RFA-CA-22-039) is a National Institutes of Health cooperative agreement designed to support the clinical validation stage of cancer early-detection research. Its central purpose is to strengthen and expand the Early Detection Research Network (EDRN, edrn.cancer.gov), a long-running national infrastructure focused on moving promising biomarkers and imaging approaches from discovery into rigorous testing and, ultimately, real-world clinical use. The program emphasizes methods that can detect cancers at earlier, more treatable stages and translate validated findings into clinical tests that can be used in healthcare settings.

A key feature of this opportunity is the focus on clinical validation, meaning applicants are expected to help run or contribute to well-structured studies that determine whether candidate biomarkers or imaging tools actually perform reliably in relevant patient populations and intended-use settings. The EDRN is positioned as an established, multicenter system for this work, with a track record that includes completion of more than 10 multicenter validation studies. Funding through a U01 mechanism signals that awardees will not simply receive funds and operate independently; instead, they will participate in a cooperative agreement where NIH has substantial scientific and programmatic involvement. This arrangement typically supports coordinated planning, common protocols, data and specimen standards, and network-wide collaboration to ensure results are reproducible and clinically meaningful. The “Clinical Trial Optional” language indicates that projects may include clinical trials if appropriate, but clinical trial activity is not automatically required for every application.

In terms of who can apply, eligibility is broad and spans many types of U.S.-based organizations. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations that are not federally recognized tribal governments; nonprofits both with and without 501(c)(3) status (as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; small businesses; and certain “other” entities as permitted under NIH rules. The notice also highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. Taken together, this reflects an intent to encourage participation from a wide range of institutional types, including organizations that serve historically underrepresented communities.

At the same time, the opportunity places clear limits on non-U.S. participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply either. However, “foreign components” as defined by the NIH Grants Policy Statement are allowed, meaning a U.S. applicant organization can include certain types of foreign involvement when it meets NIH’s definition and requirements (for example, specialized expertise, resources, or study elements that must be conducted abroad), but the overall application and award must remain U.S.-based.

Administratively, this opportunity is categorized as a discretionary program using a cooperative agreement funding instrument, and it is tied to the health and education funding activity category under CFDA number 93.394. The listing shows an original closing date of 2022-09-19 and a creation date of 2022-07-18. An award ceiling and expected number of awards are not specified in the provided source data, which often means applicants need to consult the full RFA or NIH notices for budget expectations, project periods, and any network-specific caps or guidance. Overall, the opportunity is best understood as support for organizations prepared to operate as part of a coordinated national network that validates early cancer detection biomarkers and imaging approaches through multicenter clinical research, with the explicit goal of producing evidence strong enough to support translation into clinically usable tests.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394.
  • This funding opportunity was created on 2022-07-18.
  • Applicants must submit their applications by 2022-09-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 22 039

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: USAID/Bangladesh Request for Information on USAID’s Accelerating Reductions in Adolescent Childbearing

Previous opportunity: BSEE Experienced Services Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 22 039

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 22 039) also looked into and applied for these:

Funding Opportunity
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) Apply for RFA CA 22 040

Funding Number: RFA CA 22 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed) Apply for RFA MH 22 191

Funding Number: RFA MH 22 191
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required) Apply for RFA MH 22 190

Funding Number: RFA MH 22 190
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 22 218

Funding Number: PAR 22 218
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cellular and Molecular Mechanisms of Prion-Like Aggregate Seeding, Propagation, and Neurotoxicity in AD/ADRD (R01 Clinical Trial Not Allowed) Apply for PAR 23 023

Funding Number: PAR 23 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required) Apply for RFA DA 23 048

Funding Number: RFA DA 23 048
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 22 219

Funding Number: PAR 22 219
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
NCI Outstanding Investigator Award (R35 Clinical Trial Optional) Apply for RFA CA 22 045

Funding Number: RFA CA 22 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional) Apply for RFA DA 23 049

Funding Number: RFA DA 23 049
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional) Apply for RFA CA 22 019

Funding Number: RFA CA 22 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 015

Funding Number: RFA DE 23 015
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 016

Funding Number: RFA DE 23 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) Apply for RFA DA 23 032

Funding Number: RFA DA 23 032
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) Apply for RFA DA 23 013

Funding Number: RFA DA 23 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) Apply for RFA DA 23 028

Funding Number: RFA DA 23 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) Apply for RFA DA 23 026

Funding Number: RFA DA 23 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) Apply for RFA DA 23 029

Funding Number: RFA DA 23 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) Apply for RFA DA 23 023

Funding Number: RFA DA 23 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 025

Funding Number: RFA DA 23 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) Apply for RFA DA 23 024

Funding Number: RFA DA 23 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 22 039", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: